nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR1F—Amine ligand-binding receptors—TAAR6—cervical cancer	0.101	0.101	CbGpPWpGaD
Methylergometrine—HTR1E—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0956	0.0956	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0596	0.0596	CbGpPWpGaD
Methylergometrine—DRD1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0562	0.0562	CbGpPWpGaD
Methylergometrine—HTR2C—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0481	0.0481	CbGpPWpGaD
Methylergometrine—HTR2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0418	0.0418	CbGpPWpGaD
Methylergometrine—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—cervical cancer	0.04	0.04	CbGpPWpGaD
Methylergometrine—DRD1—G alpha (s) signalling events—TAAR6—cervical cancer	0.0232	0.0232	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0199	0.0199	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0188	0.0188	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—TAAR6—cervical cancer	0.0152	0.0152	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—TAAR6—cervical cancer	0.0143	0.0143	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—UBE3A—cervical cancer	0.0121	0.0121	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—WNT2—cervical cancer	0.0119	0.0119	CbGpPWpGaD
Methylergometrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0118	0.0118	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0117	0.0117	CbGpPWpGaD
Methylergometrine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.0114	0.0114	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—WNT2—cervical cancer	0.0112	0.0112	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0111	0.0111	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00946	0.00946	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—WNT5A—cervical cancer	0.00898	0.00898	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—TAAR6—cervical cancer	0.00893	0.00893	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—TAAR6—cervical cancer	0.00858	0.00858	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—WNT5A—cervical cancer	0.00848	0.00848	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—TAAR6—cervical cancer	0.00842	0.00842	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00822	0.00822	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—TAAR6—cervical cancer	0.0081	0.0081	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—TAAR6—cervical cancer	0.00779	0.00779	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—TAAR6—cervical cancer	0.00735	0.00735	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—TAAR6—cervical cancer	0.00721	0.00721	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—WNT2—cervical cancer	0.00697	0.00697	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—WNT2—cervical cancer	0.00658	0.00658	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—TAAR6—cervical cancer	0.00626	0.00626	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—WNT2—cervical cancer	0.00608	0.00608	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AKAP13—cervical cancer	0.00588	0.00588	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—WNT2—cervical cancer	0.00574	0.00574	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—WNT2—cervical cancer	0.00563	0.00563	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AKAP13—cervical cancer	0.00555	0.00555	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AKAP13—cervical cancer	0.00534	0.00534	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—WNT5A—cervical cancer	0.00528	0.00528	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—TAAR6—cervical cancer	0.00505	0.00505	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKAP13—cervical cancer	0.00504	0.00504	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—WNT5A—cervical cancer	0.00498	0.00498	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—WNT2—cervical cancer	0.00489	0.00489	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00488	0.00488	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—TAAR6—cervical cancer	0.00476	0.00476	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—WNT5A—cervical cancer	0.00461	0.00461	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TAAR6—cervical cancer	0.0046	0.0046	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TAAR6—cervical cancer	0.00458	0.00458	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—WNT5A—cervical cancer	0.00435	0.00435	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TAAR6—cervical cancer	0.00434	0.00434	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TAAR6—cervical cancer	0.00432	0.00432	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—WNT5A—cervical cancer	0.00426	0.00426	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TAAR6—cervical cancer	0.00407	0.00407	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.0037	0.0037	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TAAR6—cervical cancer	0.0037	0.0037	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—WNT2—cervical cancer	0.00359	0.00359	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—WNT2—cervical cancer	0.00358	0.00358	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00354	0.00354	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKAP13—cervical cancer	0.00346	0.00346	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—WNT2—cervical cancer	0.00339	0.00339	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—WNT2—cervical cancer	0.00337	0.00337	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.00326	0.00326	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.00321	0.00321	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKAP13—cervical cancer	0.00316	0.00316	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.00314	0.00314	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKAP13—cervical cancer	0.00298	0.00298	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKAP13—cervical cancer	0.00296	0.00296	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—WNT2—cervical cancer	0.00289	0.00289	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKAP13—cervical cancer	0.00279	0.00279	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—WNT5A—cervical cancer	0.00272	0.00272	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.00271	0.00271	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.00271	0.00271	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—WNT5A—cervical cancer	0.00257	0.00257	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—WNT5A—cervical cancer	0.00256	0.00256	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TAAR6—cervical cancer	0.00255	0.00255	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00254	0.00254	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKAP13—cervical cancer	0.00253	0.00253	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.00251	0.00251	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00245	0.00245	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00242	0.00242	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.0022	0.0022	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.00219	0.00219	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.00218	0.00218	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00214	0.00214	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.00211	0.00211	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—WNT2—cervical cancer	0.00199	0.00199	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NOTCH2—cervical cancer	0.00191	0.00191	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.0019	0.0019	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.0019	0.0019	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.00186	0.00186	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOTCH2—cervical cancer	0.0018	0.0018	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.00179	0.00179	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.00175	0.00175	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00173	0.00173	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.00171	0.00171	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.0016	0.0016	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HES1—cervical cancer	0.00157	0.00157	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.00151	0.00151	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.0015	0.0015	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.0015	0.0015	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.00148	0.00148	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HES1—cervical cancer	0.00148	0.00148	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TERT—cervical cancer	0.00137	0.00137	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.0013	0.0013	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TERT—cervical cancer	0.0013	0.0013	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.00129	0.00129	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—FGFR3—cervical cancer	0.00126	0.00126	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—FGFR3—cervical cancer	0.00119	0.00119	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NOTCH1—cervical cancer	0.00118	0.00118	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.00112	0.00112	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.00112	0.00112	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOTCH1—cervical cancer	0.00112	0.00112	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.00106	0.00106	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EGFR—cervical cancer	0.00105	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EGFR—cervical cancer	0.000995	0.000995	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000922	0.000922	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000907	0.000907	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MTOR—cervical cancer	0.000887	0.000887	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000869	0.000869	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MTOR—cervical cancer	0.000836	0.000836	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CASP3—cervical cancer	0.000816	0.000816	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000808	0.000808	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000788	0.000788	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CTNNB1—cervical cancer	0.000786	0.000786	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CASP3—cervical cancer	0.000769	0.000769	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000762	0.000762	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000744	0.000744	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	0.000742	0.000742	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000741	0.000741	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000699	0.000699	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000696	0.000696	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—STAT3—cervical cancer	0.000685	0.000685	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000656	0.000656	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000652	0.000652	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA9—cervical cancer	0.000648	0.000648	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—cervical cancer	0.000646	0.000646	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000646	0.000646	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—cervical cancer	0.000623	0.000623	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.00062	0.00062	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000598	0.000598	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—cervical cancer	0.000587	0.000587	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000585	0.000585	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000566	0.000566	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000562	0.000562	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—cervical cancer	0.000523	0.000523	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.000522	0.000522	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000519	0.000519	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.0005	0.0005	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—cervical cancer	0.000493	0.000493	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000492	0.000492	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000488	0.000488	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.00048	0.00048	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000462	0.000462	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000452	0.000452	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000436	0.000436	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000434	0.000434	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000421	0.000421	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—cervical cancer	0.000403	0.000403	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—cervical cancer	0.000387	0.000387	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—cervical cancer	0.00038	0.00038	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	0.000373	0.000373	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—cervical cancer	0.000366	0.000366	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MTOR—cervical cancer	0.000365	0.000365	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—cervical cancer	0.000345	0.000345	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—cervical cancer	0.000336	0.000336	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—cervical cancer	0.000325	0.000325	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	0.000324	0.000324	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—cervical cancer	0.000308	0.000308	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—cervical cancer	0.000296	0.000296	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—cervical cancer	0.00029	0.00029	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—cervical cancer	0.000282	0.000282	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—cervical cancer	0.000263	0.000263	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—cervical cancer	0.000257	0.000257	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—cervical cancer	0.000248	0.000248	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—cervical cancer	0.000215	0.000215	CbGpPWpGaD
